Edap Tms (EDAP) Stock Price

Edap Tms Price

NASDAQ·CLOSED
5.68EUR+0.50 (+9.21 %)
Market closed

Over the last 19 years Edap Tms grew revenue by 6.1% annually, reaching 70.75 M EUR. Earnings per share have declined at 15.1% per year over the last 13 years. For Edap Tms, the net margin of -41.5% is down versus 1.6% a few years ago. The consensus 12-month price target for Edap Tms is 3.59 EUR, about 36.9% below where the stock trades today. Of 9 analysts, 6 rate the stock a buy — an overall Buy consensus.

Edap Tms stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Edap Tms over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Edap Tms stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Edap Tms's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Edap Tms Stock Price History
DateEdap Tms Price
7/20/20265.68 EUR
7/1/20265.18 EUR
6/17/20264.81 EUR
6/15/20264.75 EUR
6/11/20264.72 EUR
5/14/20263.54 EUR
Access this data via the Eulerpool API

Edap Tms Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
47.44 M EUR
306,311.10 EUR
-1.94 M EUR
Jan 1, 2021
50.18 M EUR
-1.84 M EUR
797,092.10 EUR
Jan 1, 2022
62.75 M EUR
-4.85 M EUR
-3.34 M EUR
Jan 1, 2023
68.80 M EUR
-22.56 M EUR
-24.12 M EUR
Jan 1, 2024
73.01 M EUR
-23.38 M EUR
-21.66 M EUR
Jan 1, 2025
70.75 M EUR
-28.47 M EUR
-29.34 M EUR
Jan 1, 2026 (e)
74.97 M EUR
-22.88 M EUR
-30.66 M EUR
Jan 1, 2027 (e)
79.81 M EUR
-20.62 M EUR
-22.06 M EUR

Edap Tms Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 26, 2026, 3:25 PM
 
REVENUEM EUR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM EUR
EBITM EUR
EBIT MARGIN%
NET INCOMEM EUR
NET INCOME GROWTH%
SHARESM
201220132014201520162017201820192020202120222023202420252026e2027e
29.0027.0030.0036.0040.0040.0044.0051.0047.0050.0062.0068.0073.0070.0074.0079.00
16.00-6.9011.1120.0011.1110.0015.91-7.846.3824.009.687.35-4.115.716.76
37.9337.0440.0041.6745.0040.0043.1845.1042.5540.0043.5539.7141.1042.8642.8642.86
11.0010.0012.0015.0018.0016.0019.0023.0020.0020.0027.0027.0030.0030.0031.7133.86
-2.00-3.00-1.00-2.00-1.002.00-1.00-4.00-22.00-23.00-28.00-22.00-20.00
-6.90-11.11-3.33-5.00-2.273.92-2.00-6.45-32.35-31.51-40.00-29.73-25.32
-8.00-5.00-1.004.001.00-1.00-3.00-24.00-21.00-29.00-30.00-22.00
700.00-37.50-500.00-200.00700.00-12.5038.103.45-26.67
18.2621.7924.8728.8528.7329.0029.3529.0530.2234.5636.9237.0737.2337.4537.4537.45
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Edap Tms generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Edap Tms retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Edap Tms's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Edap Tms has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Edap Tms's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Edap Tms stock margins

The Edap Tms margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Edap Tms. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Edap Tms.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
44.11 %
0.65 %
-4.09 %
Jan 1, 2021
41.81 %
-3.66 %
1.59 %
Jan 1, 2022
43.90 %
-7.72 %
-5.32 %
Jan 1, 2023
40.40 %
-32.79 %
-35.05 %
Jan 1, 2024
41.42 %
-32.03 %
-29.66 %
Jan 1, 2025
42.54 %
-40.25 %
-41.47 %
Jan 1, 2026 (e)
42.54 %
-30.52 %
-40.90 %
Jan 1, 2027 (e)
42.54 %
-25.83 %
-27.64 %

Edap Tms Stock Revenue, EBIT, Earnings per Share

The Edap Tms earnings per share therefore indicates how much revenue Edap Tms has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
1.57 EUR
0.01 EUR
-0.06 EUR
Jan 1, 2021
1.45 EUR
-0.05 EUR
0.02 EUR
Jan 1, 2022
1.70 EUR
-0.13 EUR
-0.09 EUR
Jan 1, 2023
1.86 EUR
-0.61 EUR
-0.65 EUR
Jan 1, 2024
1.96 EUR
-0.63 EUR
-0.58 EUR
Jan 1, 2025
1.89 EUR
-0.76 EUR
-0.78 EUR
Jan 1, 2026 (e)
2.01 EUR
-0.61 EUR
-0.82 EUR
Jan 1, 2027 (e)
2.13 EUR
-0.55 EUR
-0.59 EUR

Edap Tms business model & stock analysis

Edap Tms SA is a French company specialized in the development and marketing of medical devices. The company was founded in 1979 and has its headquarters in Vaulx-en-Velin, France. With over 300 employees, Edap Tms SA operates worldwide and has branches in the USA, Asia, and Europe. The company's business model is based on the development of non-invasive medical devices, particularly HIFU (High-Intensity Focused Ultrasound) devices. With its technology, the company has developed a revolutionary new procedure for tumor treatment that can replace traditional radiation therapy. HIFU offers a gentler and more precise alternative for tumor treatment without damaging the surrounding tissue. Edap Tms SA offers its products and services in four main business areas: 1. HIFU systems for the treatment of prostate cancer: Edap Tms SA has developed a HIFU system capable of treating prostate cancer without invasive procedures. The system uses a special ultrasound probe inserted into the rectum to locate the tumor and direct targeted sound waves at the tumor, destroying cancer cells. 2. HIFU systems for the treatment of kidney cancer: Edap Tms SA has also developed a HIFU system capable of treating kidney cancer tumors. It works similarly to the prostate cancer system, effectively destroying the tumor through targeted sound waves. 3. Mobile HIFU devices: Edap Tms SA has developed mobile HIFU devices suitable for use in hospitals and clinics. These devices can be quickly and easily transported from room to room, allowing medical professionals to perform HIFU treatments without the need for additional equipment. 4. Bladder cancer treatment technology: Edap Tms SA has also developed technology used in the treatment of bladder cancer. The system also utilizes HIFU technology to destroy tumor cells, but it is introduced through the urethra and focuses on the tumor in the bladder. Edap Tms SA is a global leader in the development and marketing of HIFU systems. The company aims to improve cancer treatment and provide patients with a more effective and gentler alternative to traditional radiation therapy. With a wide range of products suitable for various types of cancer and a strong presence in the USA, Europe, and Asia, Edap Tms SA is a highly regarded brand in the medical device field. Overall, Edap Tms SA is a company with a rich history that focuses on innovative technologies and continuously strives to improve the lives of cancer patients. With its HIFU portfolio and strong market presence, the company is on track to achieve its goals and solidify its position as one of the leading providers of medical devices worldwide.

Edap Tms SWOT Analysis

Strengths

Edap Tms SA possesses several strengths that contribute to its competitive advantage:

  • Advanced medical technology and expertise
  • Strong intellectual property portfolio
  • Established global presence and distribution network
  • Proven track record of successful product development
  • Strong financial performance and stability

Weaknesses

Despite its strengths, Edap Tms SA faces certain weaknesses that may hinder its growth:

  • Reliance on a limited product portfolio
  • Potential vulnerability to market fluctuations
  • Dependency on key personnel and experts
  • Need for continuous investment in research and development
  • Limited market share compared to some competitors

Opportunities

There are several opportunities for Edap Tms SA to exploit and expand its business:

  • Growing demand for minimally invasive medical procedures
  • Emerging markets with untapped potential
  • Increased healthcare spending worldwide
  • Potential partnerships and collaborations
  • Technological advancements in medical devices

Threats

Despite the opportunities, Edap Tms SA must also face certain threats that could impact its operations:

  • Intense competition from established market players
  • Regulatory and compliance challenges
  • Economic downturns affecting healthcare budgets
  • Uncertainty surrounding healthcare policies
  • Rapid technological advancements leading to product obsolescence

Edap Tms Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Edap Tms historical P/E ratio, EBIT multiple, and P/S ratio

Edap Tms annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Edap Tms shares outstanding

The number of shares of Edap Tms was 37.45 M in 2025. This indicates how many shares Edap Tms is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
30.22 M Stocks
Jan 1, 2021
34.56 M Stocks
Jan 1, 2022
36.92 M Stocks
Jan 1, 2023
37.07 M Stocks
Jan 1, 2024
37.23 M Stocks
Jan 1, 2025
37.45 M Stocks
Jan 1, 2026 (e)
37.45 M Stocks
Jan 1, 2027 (e)
37.45 M Stocks

Current Edap Tms forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
100.00 %
Buy66.67 % (6)
Hold33.33 % (3)
Sell0.00 % (0)
12M Price Target
3.59
Last Price
5.68
Currency
EUR
12M Return Potential
-36.86 %
LTM Return
0 %

Edap Tms Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
5/7/2026-0.19EUR14.44 MEUR2026 Q1
3/25/2026-0.13EUR18.73 MEUR2025 Q4
11/7/2024-0.15EUR15.54 MEUR2024 Q3
5/15/2024-0.09EUR14.63 MEUR2024 Q1
3/28/2024-0.05EUR16.83 MEUR2023 Q4
11/14/2023-0.05EUR15.59 MEUR2023 Q3
8/22/2023-0.02EUR15.72 MEUR2023 Q2
5/15/2023-0.01EUR14.58 MEUR2023 Q1
3/28/2023-0.01EUR15.45 MEUR2022 Q4
11/16/2022-0.06EUR12.23 MEUR2022 Q3

Edap Tms shareholder structure

% Name
19.54869%
Soleus Capital Management, L.P.
Soleus Capital Management, L.P.
8.99326%
Morgan Stanley & Co. International Plc
Morgan Stanley & Co. International Plc
3.39663%
Rock Springs Capital Management LP
Rock Springs Capital Management LP
1.48075%
Bruce & Company, Inc.
Bruce & Company, Inc.
0.60521%
Apis Capital Advisors LLC
Apis Capital Advisors LLC
0.46717%
UBS Financial Services, Inc.
UBS Financial Services, Inc.

Edap Tms Executives and Management Board

LW

Dr. Lance Willsey

(63)

Interim Independent Chairman of the Board · since 2023

RR

Mr. Ryan Rhodes

(63)

Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc · since 2021

KM

Mr. Kenneth Mobeck

(54)

Chief Financial Officer

JB

Mr. Jean-Francois Bachelard

(61)

President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)

FP

Mr. Frederic Pech

(56)

President of EDAP TMS France SAS

Frequently asked questions about Edap Tms

The business model of Edap Tms SA revolves around providing innovative medical devices and solutions for the treatment of urology and other diseases. With a focus on High-Intensity Focused Ultrasound (HIFU) technology, Edap Tms SA aims to enhance patient care and offer non-invasive, personalized treatment options. By developing cutting-edge medical devices such as Ablatherm® and Focal One®, the company enables healthcare professionals to perform precise and targeted therapeutic procedures. Edap Tms SA's business model emphasizes continuous research and development to stay at the forefront of medical technology advancements, ultimately improving patient outcomes in urology and beyond.

All fundamentals and in-depth analysis of Edap Tms

Our stock analysis for Edap Tms stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Edap Tms. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.